_id
691483f8ccc777a4e85d94b8
Ticker
NRXS
Name
Neuraxis, Inc.
Exchange
NYSE MKT
Address
11611 North Meridian St, Carmel, IN, United States, 46032
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://neuraxis.com
Description
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Last Close
4.42
Volume
75549
Current Price
4.86
Change
-0.08
Last Updated
2026-01-05T11:40:47.413Z
Image
data:image/webp;base64,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
Ipo Date
2023-08-09T00:00:00.000Z
Market Cap
23467790
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
5
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
811414
Cost Of Revenue
135487
Gross Profit
675927
Operating Expenses
2776012
Operating Income
-2100085
Interest Expense
29661
Pretax Income
-2122796
Net Income
-2122796
Eps
-0.21490096193366687
Dividends Per Share
-
Shares Outstanding
9986294
Income Tax Expense
-
EBITDA
-2076930
Operating Margin
-258.81794004047254
Total Other Income Expense Net
-22711
Cash
4377109
Short Term Investments
-
Receivables
108504
Inventories
110256
Total Current Assets
4987782
Property Plant Equipment
362692
Total Assets
5776363
Payables
886399
Short Term Debt
258492
Long Term Debt
-
Total Liabilities
3491422
Equity
2284941
Bs_currency_symbol
USD
Depreciation
16205
Change In Working Capital
63930
Cash From Operations
-1427539
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-183808
Net Change In Cash
-1611347
Cf_currency_symbol
USD
PE
-
PB
21.010248054544956
ROE
-92.9037555017832
ROA
-36.7496987291138
FCF
-1427539
Fcf Percent
-1.759322614596248
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
811414
Quarters > 0 > income Statement > cost Of Revenue
135487
Quarters > 0 > income Statement > gross Profit
675927
Quarters > 0 > income Statement > operating Expenses
2776012
Quarters > 0 > income Statement > operating Income
-2100085
Quarters > 0 > income Statement > interest Expense
29661
Quarters > 0 > income Statement > pretax Income
-2122796
Quarters > 0 > income Statement > net Income
-2122796
Quarters > 0 > income Statement > eps
-0.21490096193366687
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
9878020
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2076930
Quarters > 0 > income Statement > operating Margin
-258.81794004047254
Quarters > 0 > income Statement > total Other Income Expense Net
-22711
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4377109
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
108504
Quarters > 0 > balance Sheet > inventories
110256
Quarters > 0 > balance Sheet > total Current Assets
4987782
Quarters > 0 > balance Sheet > property Plant Equipment
362692
Quarters > 0 > balance Sheet > total Assets
5776363
Quarters > 0 > balance Sheet > payables
886399
Quarters > 0 > balance Sheet > short Term Debt
258492
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3491422
Quarters > 0 > balance Sheet > equity
2284941
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2122796
Quarters > 0 > cash Flow > depreciation
16205
Quarters > 0 > cash Flow > change In Working Capital
63930
Quarters > 0 > cash Flow > cash From Operations
-1427539
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-183808
Quarters > 0 > cash Flow > net Change In Cash
-1611347
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.21490096193366687
Quarters > 0 > ratios > PB
21.010248054544956
Quarters > 0 > ratios > ROE
-92.9037555017832
Quarters > 0 > ratios > ROA
-36.7496987291138
Quarters > 0 > ratios > FCF
-1427539
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.759322614596248
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
894086
Quarters > 1 > income Statement > cost Of Revenue
146643
Quarters > 1 > income Statement > gross Profit
747443
Quarters > 1 > income Statement > operating Expenses
2465301
Quarters > 1 > income Statement > operating Income
-1717858
Quarters > 1 > income Statement > interest Expense
13434
Quarters > 1 > income Statement > pretax Income
-1690418
Quarters > 1 > income Statement > net Income
-1690418
Quarters > 1 > income Statement > eps
-0.19839199041944952
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8520596
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1664099
Quarters > 1 > income Statement > operating Margin
-192.13565585413482
Quarters > 1 > income Statement > total Other Income Expense Net
27440
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5988456
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
128518
Quarters > 1 > balance Sheet > inventories
131432
Quarters > 1 > balance Sheet > total Current Assets
6618731
Quarters > 1 > balance Sheet > property Plant Equipment
741471
Quarters > 1 > balance Sheet > total Assets
7087999
Quarters > 1 > balance Sheet > payables
464518
Quarters > 1 > balance Sheet > short Term Debt
259763
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2834705
Quarters > 1 > balance Sheet > equity
4253294
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1690418
Quarters > 1 > cash Flow > depreciation
12885
Quarters > 1 > cash Flow > change In Working Capital
10223
Quarters > 1 > cash Flow > cash From Operations
-1467490
Quarters > 1 > cash Flow > capital Expenditures
7288
Quarters > 1 > cash Flow > cash From Investing
-7288
Quarters > 1 > cash Flow > cash From Financing
5457864
Quarters > 1 > cash Flow > net Change In Cash
3983086
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.19839199041944952
Quarters > 1 > ratios > PB
9.736006154288887
Quarters > 1 > ratios > ROE
-39.743737442086065
Quarters > 1 > ratios > ROA
-23.849015780053016
Quarters > 1 > ratios > FCF
-1474778
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.6494811461089873
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
895655
Quarters > 2 > income Statement > cost Of Revenue
139475
Quarters > 2 > income Statement > gross Profit
756180
Quarters > 2 > income Statement > operating Expenses
3051278
Quarters > 2 > income Statement > operating Income
-2295098
Quarters > 2 > income Statement > interest Expense
2237
Quarters > 2 > income Statement > pretax Income
-2278684
Quarters > 2 > income Statement > net Income
-2278684
Quarters > 2 > income Statement > eps
-0.30530718644596466
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7463578
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2270091
Quarters > 2 > income Statement > operating Margin
-256.2479972757368
Quarters > 2 > income Statement > total Other Income Expense Net
16414
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2005370
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
243708
Quarters > 2 > balance Sheet > inventories
37421
Quarters > 2 > balance Sheet > total Current Assets
2541026
Quarters > 2 > balance Sheet > property Plant Equipment
374653
Quarters > 2 > balance Sheet > total Assets
3029809
Quarters > 2 > balance Sheet > payables
535017
Quarters > 2 > balance Sheet > short Term Debt
150207
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2771330
Quarters > 2 > balance Sheet > equity
258479
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2278684
Quarters > 2 > cash Flow > depreciation
6356
Quarters > 2 > cash Flow > change In Working Capital
550441
Quarters > 2 > cash Flow > cash From Operations
-1603655
Quarters > 2 > cash Flow > capital Expenditures
18000
Quarters > 2 > cash Flow > cash From Investing
-18000
Quarters > 2 > cash Flow > cash From Financing
-69845
Quarters > 2 > cash Flow > net Change In Cash
-1691500
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.30530718644596466
Quarters > 2 > ratios > PB
140.3324412428089
Quarters > 2 > ratios > ROE
-881.5741317476468
Quarters > 2 > ratios > ROA
-75.20883329609227
Quarters > 2 > ratios > FCF
-1621655
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.8105799666166102
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
761165
Quarters > 3 > income Statement > cost Of Revenue
105053
Quarters > 3 > income Statement > gross Profit
656112
Quarters > 3 > income Statement > operating Expenses
2122704
Quarters > 3 > income Statement > operating Income
-1466592
Quarters > 3 > income Statement > interest Expense
2394
Quarters > 3 > income Statement > pretax Income
-1447905
Quarters > 3 > income Statement > net Income
-1447905
Quarters > 3 > income Statement > eps
-0.2092684849456278
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6918887
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1438660
Quarters > 3 > income Statement > operating Margin
-192.67727759421413
Quarters > 3 > income Statement > total Other Income Expense Net
18687
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3696870
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
244618
Quarters > 3 > balance Sheet > inventories
44328
Quarters > 3 > balance Sheet > total Current Assets
4266183
Quarters > 3 > balance Sheet > property Plant Equipment
374638
Quarters > 3 > balance Sheet > total Assets
4757572
Quarters > 3 > balance Sheet > payables
596946
Quarters > 3 > balance Sheet > short Term Debt
216906
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2689824
Quarters > 3 > balance Sheet > equity
2067748
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1447905
Quarters > 3 > cash Flow > depreciation
6851
Quarters > 3 > cash Flow > change In Working Capital
-405244
Quarters > 3 > cash Flow > cash From Operations
-1758167
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
5194152
Quarters > 3 > cash Flow > net Change In Cash
3435985
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.2092684849456278
Quarters > 3 > ratios > PB
16.262035228664228
Quarters > 3 > ratios > ROE
-70.02328136697508
Quarters > 3 > ratios > ROA
-30.433696011326788
Quarters > 3 > ratios > FCF
-1758167
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-2.309836894760006
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2685925
Annuals > 0 > income Statement > cost Of Revenue
362002
Annuals > 0 > income Statement > gross Profit
2323923
Annuals > 0 > income Statement > operating Expenses
9480740
Annuals > 0 > income Statement > operating Income
-7156817
Annuals > 0 > income Statement > interest Expense
300715
Annuals > 0 > income Statement > pretax Income
-8241501
Annuals > 0 > income Statement > net Income
-8241501
Annuals > 0 > income Statement > eps
-1.191159936562051
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6918887
Annuals > 0 > income Statement > income Tax Expense
-8241501
Annuals > 0 > income Statement > EBITDA
-7902955
Annuals > 0 > income Statement > operating Margin
-266.4563232405968
Annuals > 0 > income Statement > total Other Income Expense Net
-1084684
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3696870
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
244618
Annuals > 0 > balance Sheet > inventories
44328
Annuals > 0 > balance Sheet > total Current Assets
4266183
Annuals > 0 > balance Sheet > property Plant Equipment
374638
Annuals > 0 > balance Sheet > total Assets
4757572
Annuals > 0 > balance Sheet > payables
596946
Annuals > 0 > balance Sheet > short Term Debt
216906
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2689824
Annuals > 0 > balance Sheet > equity
2067748
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8241501
Annuals > 0 > cash Flow > depreciation
37831
Annuals > 0 > cash Flow > change In Working Capital
141398
Annuals > 0 > cash Flow > cash From Operations
-6098264
Annuals > 0 > cash Flow > capital Expenditures
27776
Annuals > 0 > cash Flow > cash From Investing
-27776
Annuals > 0 > cash Flow > cash From Financing
9744350
Annuals > 0 > cash Flow > net Change In Cash
3618310
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.191159936562051
Annuals > 0 > ratios > PB
14.923596115193922
Annuals > 0 > ratios > ROE
-398.5737623733646
Annuals > 0 > ratios > ROA
-173.2291387287465
Annuals > 0 > ratios > FCF
-6126040
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.280793395199047
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2460049
Annuals > 1 > income Statement > cost Of Revenue
303345
Annuals > 1 > income Statement > gross Profit
2156704
Annuals > 1 > income Statement > operating Expenses
8821199
Annuals > 1 > income Statement > operating Income
-6664495
Annuals > 1 > income Statement > interest Expense
5358038
Annuals > 1 > income Statement > pretax Income
-14626683
Annuals > 1 > income Statement > net Income
-14626683
Annuals > 1 > income Statement > eps
-2.3230493514554276
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6296329
Annuals > 1 > income Statement > income Tax Expense
5362816
Annuals > 1 > income Statement > EBITDA
-9227920
Annuals > 1 > income Statement > operating Margin
-270.9090347387389
Annuals > 1 > income Statement > total Other Income Expense Net
-7962188
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
78560
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
73167
Annuals > 1 > balance Sheet > inventories
21220
Annuals > 1 > balance Sheet > total Current Assets
242610
Annuals > 1 > balance Sheet > property Plant Equipment
158815
Annuals > 1 > balance Sheet > total Assets
509498
Annuals > 1 > balance Sheet > payables
1204219
Annuals > 1 > balance Sheet > short Term Debt
197189
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1912739
Annuals > 1 > balance Sheet > equity
-1403241
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-14626683
Annuals > 1 > cash Flow > depreciation
40725
Annuals > 1 > cash Flow > change In Working Capital
-665747
Annuals > 1 > cash Flow > cash From Operations
-6693978
Annuals > 1 > cash Flow > capital Expenditures
71781
Annuals > 1 > cash Flow > cash From Investing
-71781
Annuals > 1 > cash Flow > cash From Financing
6590620
Annuals > 1 > cash Flow > net Change In Cash
-175139
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.3230493514554276
Annuals > 1 > ratios > PB
-20.011977514910125
Annuals > 1 > ratios > ROE
1042.3500311065598
Annuals > 1 > ratios > ROA
-2870.802829451735
Annuals > 1 > ratios > FCF
-6765759
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.75025375510813
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2684735
Annuals > 2 > income Statement > cost Of Revenue
297060
Annuals > 2 > income Statement > gross Profit
2387675
Annuals > 2 > income Statement > operating Expenses
5759913
Annuals > 2 > income Statement > operating Income
-3372238
Annuals > 2 > income Statement > interest Expense
417601
Annuals > 2 > income Statement > pretax Income
-4780061
Annuals > 2 > income Statement > net Income
-4780061
Annuals > 2 > income Statement > eps
-0.5682265554557672
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8412245
Annuals > 2 > income Statement > income Tax Expense
429557
Annuals > 2 > income Statement > EBITDA
-4325327
Annuals > 2 > income Statement > operating Margin
-125.60785328905833
Annuals > 2 > income Statement > total Other Income Expense Net
-1407823
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
253699
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
174399
Annuals > 2 > balance Sheet > inventories
48133
Annuals > 2 > balance Sheet > total Current Assets
476957
Annuals > 2 > balance Sheet > property Plant Equipment
189393
Annuals > 2 > balance Sheet > total Assets
1480644
Annuals > 2 > balance Sheet > payables
1592116
Annuals > 2 > balance Sheet > short Term Debt
522622
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7054257
Annuals > 2 > balance Sheet > equity
-5573613
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4780061
Annuals > 2 > cash Flow > depreciation
37133
Annuals > 2 > cash Flow > change In Working Capital
1270394
Annuals > 2 > cash Flow > cash From Operations
-2298004
Annuals > 2 > cash Flow > capital Expenditures
61205
Annuals > 2 > cash Flow > cash From Investing
-61205
Annuals > 2 > cash Flow > cash From Financing
2292050
Annuals > 2 > cash Flow > net Change In Cash
-67159
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.5682265554557672
Annuals > 2 > ratios > PB
-6.731470717468184
Annuals > 2 > ratios > ROE
85.76234123180063
Annuals > 2 > ratios > ROA
-322.8366170396125
Annuals > 2 > ratios > FCF
-2359209
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.8787492992790722
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2721286
Annuals > 3 > income Statement > cost Of Revenue
467656
Annuals > 3 > income Statement > gross Profit
2253630
Annuals > 3 > income Statement > operating Expenses
5223664
Annuals > 3 > income Statement > operating Income
-2970034
Annuals > 3 > income Statement > interest Expense
36928
Annuals > 3 > income Statement > pretax Income
-3028032
Annuals > 3 > income Statement > net Income
-3028032
Annuals > 3 > income Statement > eps
-0.5625646882174227
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5382549
Annuals > 3 > income Statement > income Tax Expense
45200
Annuals > 3 > income Statement > EBITDA
-2954396
Annuals > 3 > income Statement > operating Margin
-109.14082533037688
Annuals > 3 > income Statement > total Other Income Expense Net
-57998
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
320858
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
115301
Annuals > 3 > balance Sheet > inventories
39180
Annuals > 3 > balance Sheet > total Current Assets
491009
Annuals > 3 > balance Sheet > property Plant Equipment
245517
Annuals > 3 > balance Sheet > total Assets
760482
Annuals > 3 > balance Sheet > payables
483790
Annuals > 3 > balance Sheet > short Term Debt
277989
Annuals > 3 > balance Sheet > long Term Debt
51692
Annuals > 3 > balance Sheet > total Liabilities
1586142
Annuals > 3 > balance Sheet > equity
-825660
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3028032
Annuals > 3 > cash Flow > depreciation
36708
Annuals > 3 > cash Flow > change In Working Capital
644434
Annuals > 3 > cash Flow > cash From Operations
-2234326
Annuals > 3 > cash Flow > capital Expenditures
1390
Annuals > 3 > cash Flow > cash From Investing
-1390
Annuals > 3 > cash Flow > cash From Financing
661099
Annuals > 3 > cash Flow > net Change In Cash
-1574617
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.5625646882174227
Annuals > 3 > ratios > PB
-29.075126008284283
Annuals > 3 > ratios > ROE
366.74078918683233
Annuals > 3 > ratios > ROA
-398.17273781627966
Annuals > 3 > ratios > FCF
-2235716
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.8215659802020074
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.21490096193366687
Valuation > metrics > PB
21.010248054544956
Valuation > final Score
20
Valuation > verdict
600.3% Overvalued
Profitability > metrics > ROE
-92.9037555017832
Profitability > metrics > ROA
-42.559919419092495
Profitability > metrics > Net Margin
-2.616168811482178
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5280140712604833
Risk > metrics > Interest Coverage
-70.80290617308924
Risk > final Score
-253
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.356556213648286
Liquidity > metrics > Quick Ratio
4.2602535961938734
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-463
Prev Risks > 1
-4098
Prev Risks > 2
-2420
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:18:19.968Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.24
Earnings History > 0 > eps Estimate
-0.24
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
0
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.22
Earnings History > 1 > eps Estimate
-0.19
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-15.7895
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.33
Earnings History > 2 > eps Estimate
-0.24
Earnings History > 2 > eps Difference
-0.09
Earnings History > 2 > surprise Percent
-37.5
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.205
Earnings History > 3 > eps Estimate
0.04
Earnings History > 3 > eps Difference
-0.245
Earnings History > 3 > surprise Percent
-612.5
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.251
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.4216
Earnings History > 5 > eps Estimate
-0.05
Earnings History > 5 > eps Difference
-0.3716
Earnings History > 5 > surprise Percent
-743.2
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-20
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.8163
Earnings History > 6 > eps Estimate
-0.1
Earnings History > 6 > eps Difference
-0.7163
Earnings History > 6 > surprise Percent
-716.3
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2547
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
-0.1047
Earnings History > 7 > surprise Percent
-69.8
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-20
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.35
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
-1.18
Earnings History > 8 > surprise Percent
-694.1176
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-18
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.21
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-1.21
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.38
Earnings History > 10 > surprise Percent
-
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANew insurance code could make nerve therapy for chronic illness easier to access - Stock Titan
1/8/2026
New insurance code could make nerve therapy for chronic illness easier to access Stock Titan
Read more →Aug Update: Why ASTI stock is seen as undervalued - July 2025 Volume & Long Hold Capital Preservation Tips Bộ Nội Vụ
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$5
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Neuraxis, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.24
EPS Estimate
-0.24
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.